Madrigal Pharmaceuticals
MDGL
MDGL
320 hedge funds and large institutions have $7.82B invested in Madrigal Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 109 increasing their positions, 92 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 283 → 320 (+37)
10% more capital invested
Capital invested by funds: $7.08B → $7.82B (+$732M)
1.73% more ownership
Funds ownership: 105.25% → 106.98% (+1.7%)
Holders
320
Holding in Top 10
12
Calls
$346M
Puts
$164M
Top Buyers
| 1 | +$128M | |
| 2 | +$56.4M | |
| 3 | +$54.7M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$41.5M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$38.2M |
Top Sellers
| 1 | -$70.9M | |
| 2 | -$38.9M | |
| 3 | -$32.9M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$32.4M |
| 5 |
VPC
Vestal Point Capital
New York
|
-$29.3M |